STOCK TITAN

Insider stock sale planned under Rule 144 (NASDAQ: IONS)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An affiliate of the issuer has filed a notice under Rule 144 to sell 9,390 shares of common stock through broker Stifel Nicolaus & Company on the Nasdaq market, with an aggregate market value of $795,117. The filing notes that 161,974,393 shares of the issuer’s common stock were outstanding at the time of the notice.

The shares to be sold were acquired from the issuer through stock option exercises on three dates in 2022, 2023, and 2024, all paid in cash. The person filing the notice previously sold 16,777 shares on 11/25/2025 for gross proceeds of $1,342,160 and 3,162 shares on 09/03/2025 for gross proceeds of $192,882. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many IONS common shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 9,390 shares of common stock, with an aggregate market value of $795,117, to be sold through Stifel Nicolaus & Company on Nasdaq.

When is the proposed sale of IONS shares expected to occur?

The filing lists an approximate date of sale of 01/07/2026 for the 9,390 shares of common stock to be sold on Nasdaq.

How were the IONS shares being sold under Rule 144 originally acquired?

The shares were acquired from the issuer via stock option exercises on 01/03/2022, 01/03/2023, and 01/02/2024, with payment described as cash in each case.

What recent IONS share sales has the seller already completed?

The seller previously sold 16,777 shares of common stock on 11/25/2025 for gross proceeds of $1,342,160, and 3,162 shares on 09/03/2025 for gross proceeds of $192,882.

How many IONS shares were outstanding when this Form 144 was filed?

The notice states that 161,974,393 shares of common stock were outstanding at the time of the filing.

Which broker is handling the planned sale of IONS shares?

The proposed sale of 9,390 common shares is to be executed through Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102.

What representation does the seller make about information on the issuer?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Ionis Pharmaceuticals

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Latest SEC Filings

IONS Stock Data

12.51B
160.75M
0.65%
108.48%
6.59%
Biotechnology
Pharmaceutical Preparations
Link
United States
CARLSBAD